Skip to content

Wall Street sets NNOX stock price for the next 12 months

Wall Street sets NNOX stock price for the next 12 months
Ana Zirojevic

In a surprising turn of events, the stock of Israeli-based medical device company Nano-X Imaging (NASDAQ: NNOX) made a massive rally after technology giant Nvidia (NASDAQ: NVDA) disclosed its positions, and experts see more advances for NNOX stock price in the next 12 months.

Indeed, the shares of Nano-X Imaging, which uses artificial intelligence (AI) software to advance diagnostic medicine, surged by 50% on February 15, reaching their highest price in over six months, thanks to the positive sentiment surrounding the lesser-known NNOX stock finding its place in Nvidia’s portfolio. 

Wall Street weighs in on NNOX stock

In this context, a group of Wall Street analysts is exceptionally bullish on the price of Nano-X Imaging stock for the next 12 months, rating NNOX shares as a ‘strong buy’ with all votes on board, and no recommendations for either a ‘hold’ or a ‘sell,’ according to the latest TradingView data on February 21.

NNOX stock 12-month price targets. Source: TradingView

At the same time, the experts have offered yearly targets for Nano-X Imaging stock price over the course of the past three months, which see NNOX shares increasing further by 76.98%, toward the average price of $18.30, with the lowest target at $14.5 (+40.23%) and the highest at $22.4 (+116.63%).

NNOX stock price analysis

At press time, the price of Nano-X Imaging stock stood at $10.34, which represents a decline of 20.15% on the day, but nonetheless an increase of an impressive 67.94% across a single week, adding up to the gain of 79.51% on its monthly chart, as the most recent data suggests.

NNOX stock 30-day price chart. Source: TradingView

Notably, the recent price action has pushed NNOX to the group of the better performing stocks in the healthcare equipment industry, considering it is doing better than 91% of the other 199 stocks in the sector, as well as outperforming 94% of all other assets in the stock market in yearly terms.

Despite retracing since the Nvidia news, NNOX stock action has nonetheless demonstrated the power of such industry maneuvres to the stock market sentiment, more recently also evident in the acquisition of Vizio Holding Corp (NYSE: VZIO) by Walmart (NYSE: WMT), as Finbold reported on February 20.

Buy stocks now with eToro – trusted and advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk. 

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.